Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Purification for the Treatment of Critically Ill Patients With Pathogen Associated Shock: A Multicenter, Randomized Controlled Feasibility Trial

NCT05011656 is registered in ClinicalTrials.gov with ExThera Medical Corporation as lead sponsor.

NCT NCT05011656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05011656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Purification for the Treatment of Critically Ill Patients With Pathogen Associated Shock: A Multicenter, Randomized Controlled Feasibility Trial
Lead sponsor
ExThera Medical Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 19, 2024
Completion date
July 31, 2027
Enrollment
15 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock